These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Stimulating effect of biologically modified low density lipoproteins on ADP-induced aggregation of washed platelets persists in absence of specific binding. Volf I; Roth A; Moeslinger T; Cooper J; Schmid W; Zehetgruber M; Koller E Thromb Res; 2000 Mar; 97(6):441-9. PubMed ID: 10704653 [TBL] [Abstract][Full Text] [Related]
10. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins. Andrews HE; Aitken JW; Hassall DG; Skinner VO; Bruckdorfer KR Biochem J; 1987 Mar; 242(2):559-64. PubMed ID: 3109394 [TBL] [Abstract][Full Text] [Related]
11. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor. Sato T; Hashizume T; Nakao K; Akiba S; Fujii T Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041 [TBL] [Abstract][Full Text] [Related]
12. The interactions of modified lipoproteins with human erythrocyte membranes. Jóźwiak Z; Pałecz D; Bartosz G Biochem Mol Biol Int; 1994 Feb; 32(2):259-67. PubMed ID: 8019431 [TBL] [Abstract][Full Text] [Related]
13. Lipoproteins and the inhibitory effect of human endothelial cells on platelet function. Nordøy A; Svensson B; Wiebe D; Hoak JC Circ Res; 1978 Oct; 43(4):527-34. PubMed ID: 210972 [TBL] [Abstract][Full Text] [Related]
14. Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI. Valiyaveettil M; Kar N; Ashraf MZ; Byzova TV; Febbraio M; Podrez EA Blood; 2008 Feb; 111(4):1962-71. PubMed ID: 17993610 [TBL] [Abstract][Full Text] [Related]
15. Native and oxidized low density lipoproteins enhance platelet aggregation in whole blood. Tornvall P; Chirkova L; Toverud KD; Horowitz JD; Chirkov Y Thromb Res; 1999 Aug; 95(4):177-83. PubMed ID: 10498387 [TBL] [Abstract][Full Text] [Related]
16. Oxidized low-density lipoprotein (LDL) enhances thromboxane A(2) synthesis by platelets, but lysolecithin as a product of LDL oxidation has an inhibitory effect. Mahfouz MM; Kummerow FA Prostaglandins Other Lipid Mediat; 2000 Jul; 62(2):183-200. PubMed ID: 10938412 [TBL] [Abstract][Full Text] [Related]
17. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia. Virgolini I; Koller E; Li S; Yang Q; Banyai M; Rauscha F; Pidlich J; Pirker W; Sinzinger H Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008 [TBL] [Abstract][Full Text] [Related]
18. Reversal by high-density lipoprotein of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human platelets. Mehta JL; Chen LY J Lab Clin Med; 1996 Mar; 127(3):287-95. PubMed ID: 9273362 [TBL] [Abstract][Full Text] [Related]
19. Effect of human native low-density and high-density lipoproteins on prostaglandin production by mouse macrophage cell line P388D1: possible implications in pathogenesis of atherosclerosis. Jambou D; Dejour N; Bayer P; Poirée JC; Frédenrich A; Issa-Sayegh M; Adjovi-Desouza M; Lapalus P; Harter M Biochim Biophys Acta; 1993 May; 1168(1):115-21. PubMed ID: 8504137 [TBL] [Abstract][Full Text] [Related]
20. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin. Hassall DG; Owen JS; Bruckdorfer KR Biochem J; 1983 Oct; 216(1):43-9. PubMed ID: 6360159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]